Biocon Q4 profit drops 57%, but biosimilars business shines
Published on: May 8, 2026, 11:12 a.m. | Source: The Hindu Business Line
Biocon's Q4 profit drops 57% due to exceptional items, but biosimilars and generics segments show strong growth.
Looking for a side income?
Earn on your terms — become a freelancer with us!
Looking for a side income?
Work on your own terms — become a freelancer with us! Choose projects you love, set your own schedule, and start earning today. No fixed hours, no limits — just flexibility and freedom.
Know more